BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31958849)

  • 1. Thyroid Hormone Actions and Bone Remodeling - The Role of the Wnt Signaling Pathway.
    Lademann F; Tsourdi E; Hofbauer LC; Rauner M
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):450-454. PubMed ID: 31958849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of thyroid status on bone metabolism: a primary role for thyroid stimulating hormone or thyroid hormone?
    Galliford TM; Murphy E; Williams AJ; Bassett JH; Williams GR
    Minerva Endocrinol; 2005 Dec; 30(4):237-46. PubMed ID: 16319811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone receptor β mediates thyroid hormone effects on bone remodeling and bone mass.
    Monfoulet LE; Rabier B; Dacquin R; Anginot A; Photsavang J; Jurdic P; Vico L; Malaval L; Chassande O
    J Bone Miner Res; 2011 Sep; 26(9):2036-44. PubMed ID: 21594896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of thyroid diseases on bone].
    Tsourdi E; Lademann F; Siggelkow H
    Internist (Berl); 2018 Jul; 59(7):661-667. PubMed ID: 29744522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.
    Bassett JH; Williams GR
    Endocr Rev; 2016 Apr; 37(2):135-87. PubMed ID: 26862888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblastogenesis regulation signals in bone remodeling.
    Zuo C; Huang Y; Bajis R; Sahih M; Li YP; Dai K; Zhang X
    Osteoporos Int; 2012 Jun; 23(6):1653-63. PubMed ID: 22290242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism and Hypothyroidism in Male Mice and Their Effects on Bone Mass, Bone Turnover, and the Wnt Inhibitors Sclerostin and Dickkopf-1.
    Tsourdi E; Rijntjes E; Köhrle J; Hofbauer LC; Rauner M
    Endocrinology; 2015 Oct; 156(10):3517-27. PubMed ID: 26218891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthyroidism and Wnt Signaling Pathway: Influence on Bone Remodeling.
    Mudri D; Bilić Ćurčić I; Meštrović L; Mihaljević I; Kizivat T
    Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid and bone.
    Gogakos AI; Duncan Bassett JH; Williams GR
    Arch Biochem Biophys; 2010 Nov; 503(1):129-36. PubMed ID: 20599658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system.
    Niedźwiedzki T; Filipowska J
    J Mol Endocrinol; 2015 Oct; 55(2):R23-36. PubMed ID: 26307562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans.
    Belaya ZE; Grebennikova TA; Melnichenko GA; Nikitin AG; Solodovnikov AG; Brovkina OI; Grigoriev AU; Rozhinskaya LY; Dedov II
    Osteoporos Int; 2018 Jan; 29(1):211-221. PubMed ID: 28980049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Regulation of Bone Metabolism and Disorders by Wnt Signaling.
    Maeda K; Kobayashi Y; Koide M; Uehara S; Okamoto M; Ishihara A; Kayama T; Saito M; Marumo K
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Dickkopf-1 in Thyroid Hormone-Induced Changes of Bone Remodeling in Male Mice.
    Tsourdi E; Colditz J; Lademann F; Rijntjes E; Köhrle J; Niehrs C; Hofbauer LC; Rauner M
    Endocrinology; 2019 Mar; 160(3):664-674. PubMed ID: 30689850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid Hormone Nuclear Receptor TRα1 and Canonical WNT Pathway Cross-Regulation in Normal Intestine and Cancer.
    Sirakov M; Claret L; Plateroti M
    Front Endocrinol (Lausanne); 2021; 12():725708. PubMed ID: 34956074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--thyroid hormones].
    Kiriyama T; Okamoto S; Nagataki S
    Nihon Rinsho; 1986 Nov; 44(11):2399-403. PubMed ID: 3546791
    [No Abstract]   [Full Text] [Related]  

  • 16. Actions of thyroid hormones in bone.
    Williams GR
    Endokrynol Pol; 2009; 60(5):380-8. PubMed ID: 19885809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases.
    Brunetti G; D'Amato G; Chiarito M; Tullo A; Colaianni G; Colucci S; Grano M; Faienza MF
    World J Pediatr; 2019 Feb; 15(1):4-11. PubMed ID: 30343446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Osteoporosis treatment in patients with hyperthyroidism].
    Saito J; Nishikawa T
    Nihon Rinsho; 2009 May; 67(5):1011-6. PubMed ID: 19432125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of osteoprotegerin and vitamin D in thyroid pathology].
    Tuchendler D; Bolanowski M
    Endokrynol Pol; 2009; 60(6):470-5. PubMed ID: 20041365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of thyroid hormones in the skeleton.
    Wojcicka A; Bassett JH; Williams GR
    Biochim Biophys Acta; 2013 Jul; 1830(7):3979-86. PubMed ID: 22634735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.